CureTalks Archives - Page 2 of 2

February 4th, 2018 • •

Clinical Trials, CureTalks, New Treatments, News

[Infographic] ASCO Names CAR-T Cell Immunotherapy Clinical Cancer Advance of the Year 2017

CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have highlighted adoptive immunotherapy with chimeric antigen receptor (CAR) T cells as the…

Priya Menon

492

November 14th, 2017 • •

Clinical Trials, CureTalks, Drugs, New Treatments

CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine

Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively. Approved in August 2017, before Novartis named the drug Kymriah (Tisagenlecleucel) – it…

Shweta Mishra

331

« Previous 1 2

Category: CureTalks

[Infographic] ASCO Names CAR-T Cell Immunotherapy Clinical Cancer Advance of the Year 2017

CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine

Supporting Health Research Data Collection for the Historic Ax-4 Mission to the International Space Station

Clinical Trial Awareness: 5 Promising Pancreatic Cancer Clinical Trials That are Currently Recruiting Participants

Clinical Trial Awareness: 5 Breakthrough Clinical Trials Bringing New Insights to Diabetes Care

The Spacesuit as a Health System: What NASA’s Audit Reveals About Astronaut Safety

TrialX Expands Global Impact with Inclusive Clinical Trial Outreach, AI-Assisted Patient Recruitment Tools & Study App Milestone